HealthcareMiddle East & AfricaVerified by the Meticulous Standard

Africa Medical Devices Market (2025-2032)

The Africa Medical Devices Market was valued at $3.99 billion in 2024. This market is expected to reach $7.14 billion by 2032 from an estimated $4.26 billion in 2025, at a CAGR of 7.7 % during the forecast period of 2025-2032. Africa Medical Devices Market Size & Forecast The growth of this market

Published
Nov 2024
Pages
120
Format
PDF + Excel
Report ID
MRHC - 1041419
Base year
2024
Market size · USD billion · 2024–2032Forecast 2025–2032 · 7.7% CAGR
2024 · BASELINE
$3.99B
2032
$7.14B
CAGR 2025–2032
7.7%
$10B$7.5B$5B$2.5B0
2024
2025
'26
'27
'28
'29
'30
'31
'32

2024 baseline · 2025–2032 forecast at 7.7% CAGR · hover a bar for the value

Key highlights

01

By Product: In 2025, the Monitoring Devices Segment to Dominate the Africa Medical Devices Market By Risk Type: In 2025, the Moderate-risk Medical Devices Segment is Expected to Dominate the Africa Medical Devices Market

02

By Application: In 2025, the Cardiology Segment is Expected to Dominate the Africa Medical Devices Market

03

By End User: In 2025, the Hospitals and Clinics Segment is Expected to Account for the Largest Share of the Africa Medical Devices Market

04

By Geography: South Africa Dominates the Africa Medical Devices Market in 2025

Report summary

ParticularsDetails
Number of Pages120
FormatPDF
Forecast Period2025–2032
Base Year2024
CAGR (Value)7.7%
Market Size (Value)USD 7.14 Billion by 2032
Segments CoveredBy Product · Monitoring Devices · Diagnostic devices · Drug delivery devices · Surgical Devices · Bio implants & Stimulation Devices · Automation & Robotics · Imaging Devices · Other Devices · (Note: Other devices include immunoassay, gynecology, pediatric, urology, and cryogenic.) · By Risk Type · Low-risk Medical Devices · Moderate Risk Medical Devices · High-risk Medical Devices · By Application · Cardiology · Diagnostic Imaging · General Surgery · Orthopedics · Other Applications · (Note: Other applications include Dental, Nephrology, and Neurology) · By End User · Hospitals & Clinics · Ambulatory Surgery Centers · Diagnostic Centers & Laboratories · Pharmacies · Other End Users · (Note: Other end users include dental clinics, Blood Banks, Academic Institutes, Pharmaceutical Firms, and Ambulatory Surgical Centers (ASC)
Countries CoveredSouth Africa, Egypt, Algeria, Nigeria, Morocco, Kenya, Tunisia, Côte D’Ivoire, Tanzania, Cameroon, and the Rest of Africa.
Key CompaniesKoninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Abbott Laboratories (U.S.), Smith & Nephew Plc (U.K.), Coloplast Corp. (Denmark), Zimmer Biomet. (U.S), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company. (U.S), Olympus Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.), Cardinal Health. (U.S.), and Medtronic plc (Ireland)

Report overview

Market size trajectory
2024
USD 3.99 billion
2025
USD 4.26 billion
2032
USD 7.14 billion
~1.7× expansion 2025–2032 at 7.7% CAGR
Scope note

Segments covered: product, risk type.

The growth of this market is driven by the increasing prevalence of chronic diseases coupled with the geriatric population, technological advancements in medical devices, growing awareness about advanced medical technologies, and rising initiatives to increase accessibility to treatment. Furthermore, developing healthcare infrastructure in African countries and emerging medical tourism in African countries. are expected to generate opportunities for the stakeholders in this market.

Report infographic

Africa Medical Devices Market
Africa Medical Devices Market · Report infographic

Market dynamics

3 factors across 2 forces
01

Increasing Prevalence of Chronic Diseases Coupled with Geriatric Population

The rising prevalence of chronic diseases and the growing geriatric population in Africa are driving significant growth in the region's medical devices market. The increasing burden of chronic conditions has led to higher patient visits to healthcare facilities, thereby fueling demand for medical equipment. According to an article published by the World Economic Forum (Switzerland) in September 2022, non-communicable diseases are on the rise across the continent, with 50-88% of deaths in several African countries attributed to chronic diseases.

To address these challenges and reduce mortality rates, governments across Africa are launching various initiatives aimed at strengthening healthcare infrastructure. These programs are driving the increased use and adoption of medical devices in treatment regimens. As highlighted by the World Economic Forum, several African countries are implementing new strategies to combat chronic diseases. For example, the PEN-Plus strategy, introduced in 2022 at the 72nd session of the WHO’s Regional Committee for Africa in Lomé, Togo, urges African nations to adopt standardized programs for treating chronic and severe non-communicable diseases. These efforts are expected to further accelerate the adoption of medical devices across healthcare facilities in the region.

02

Growing Awareness about Advanced Medical Technologies

The high disease burden and shortage of skilled healthcare professionals in many African countries present significant challenges to the healthcare sector. These factors underscore the need for increased awareness of new solutions and advanced medical technologies to alleviate the strain caused by these health issues. According to the World Health Organization (WHO), the average doctor-to-population ratio in Africa is approximately two doctors per 10,000 people, compared to 35.5 doctors per 10,000 people in the United States. This disparity highlights the critical need for accessible and advanced medical technologies across the region.

Additionally, various initiatives and strategies developed by organizations to improve healthcare access in Africa have contributed to growing awareness about advanced medical technologies. For example, as reported by the African Development Bank (Côte d'Ivoire) in January 2025, the bank entered into an agreement with HealthTech Hub Africa (Rwanda) to support the development of a pan-African blueprint aimed at accelerating health tech innovations across the continent. This growing awareness of medical technologies is expected to drive demand for and increase the adoption of medical devices across African countries.

Table of contents

12 chapters · 113 sections · 120 pages · click to expand
Review the full research scope before you buy. Chapters can also be purchased individually.

1.1Market Definition
1.2Market Ecosystem
1.3Currency
1.4Key Stakeholders

Segmental analysis

SegmentLargest share (2025)Fastest growth (2025–2032)
By ProductMonitoring Devices—
01

By Product

  • The monitoring devices segment is estimated to account for the largest share of the Africa medical devices market.
  • Monitoring devices are majorly used for patients’ health monitoring in real time and quickly.
  • It helps in diagnosing & quantifying a patient’s condition.
  • Moreover, recent product launches by key market players are driving the growth of the Africa medical devices market.
  • For instance, in October 2024, Turtle Shell Technologies Private Limited (Dozee) (India) launched Dozee Pro Ex, which is an advanced ambulatory patient monitoring system.
  • Dozee Pro Ex device offers wearable wireless sensors that help in continuous monitoring of vital signs, which include blood pressure, ECG rhythm, heart rate, respiration rate, oxygen saturation, and temperature.
  • Furthermore, the availability of these devices in Africa countries also contributes to the largest share of the segment.
CoversIVDMonitoringImagingDrug DeliverySurgicalBioimplantsStimulation

Geographic analysis

01

Middle East & Africa

Largest share

In 2025, South Africa is estimated to account for the largest share of the Africa medical devices market. South Africa holds a significant share of the African medical devices market, primarily driven by the high prevalence of both communicable and non-communicable diseases, as well as the government’s increasing focus on healthcare sector development. According to the IDF Diabetes Atlas 2021, South Africa is the leading country in the region for diabetes prevalence, with 4.2 million people aged 20–79 living with the condition in 2021. This number is projected to increase by 76.3%, reaching 7.5 million by 2045. As a result, there is a growing demand for medical devices, particularly in-vitro diagnostics and diabetic care products, which are essential for diagnosing and managing both communicable and non-communicable diseases in hospitals, diagnostic labs, and home care settings. This rising adoption of medical devices to address the disease burden in the country is a key factor driving the growth of the medical devices market across Africa. South Africa to Dominate the Africa Medical Devices Market in 2025

Competitive landscape

Recent developments
  1. October 2025

    BioMérieux (France) partnered with the International Finance Corporation’s (IFC) Africa Medical Equipment Facility to provide InVitro diagnostics equipment to hospitals and standalone laboratories in Africa.

  2. January 2024

    Abbott Laboratories (U.S.) received U.S. FDA approval for the Proclaim XR spinal cord stimulation (SCS) system. This system was launched in December 2022 and is used to treat painful diabetic peripheral neuropathy (DPN).

  3. January 2024

    Abbott Laboratories (U.S.) received U.S. FDA approval for the Navitor transcatheter aortic valve implantation (TAVI) system. This system, launched in December 2022, is used to treat patients with severe aortic stenosis.

  4. January 2024

    Becton, Dickinson, and Company (BD) (U.S.) received an EUA from the US FDA for its molecular polymerase chain reaction (PCR) assay, VIASURE Monkeypox Virus Real-time PCR Reagent.

  5. December 2022

    BioMérieux (France) received the CE Mark approval for its VIDAS KUBE. This next-generation automated immunoassay system benefits clinical labs by providing results and speedy patient care.

  6. November 2022

    F. Hoffmann-La Roche (Switzerland) launched its cobas 5800 System, which is a compact, fully automated molecular laboratory instrument. This system offers a flexible polymerase chain reaction testing solution that helps clinicians diagnose infectious diseases.

Companies profiled (14)
  • Koninklijke Philips N.V. · Netherlands
  • GE HealthCare Technologies Inc. (U.S.)
  • Abbott Laboratories (U.S.)
  • Smith & Nephew Plc (U.K.)
  • Coloplast Corp. · Denmark
  • Zimmer Biomet. (U.S)
  • Siemens Healthineers AG · Germany
  • F. Hoffmann-La Roche Ltd. · Switzerland
  • Becton
  • Dickinson and Company. (U.S)
  • Olympus Corporation · Japan
  • Johnson & Johnson Services, Inc. (U.S.)
  • Cardinal Health. (U.S.)
  • Medtronic plc · Ireland

Frequently asked questions

The Africa medical devices market size was valued at $3.99 billion in 2024.

Cite this report

Meticulous Research. (2024). Africa Medical Devices Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 1041419). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/africa-medical-devices-market-6102

Search Market Intelligence

Search across reports, blogs, press releases, and industries